Review: taking Prilosec and Pravastatin sodium together


Summary

Drug interactions are reported among people who take Prilosec and Pravastatin sodium together. This review analyzes the effectiveness and drug interactions between Prilosec and Pravastatin sodium. It is created by eHealthMe based on reports of 3,630 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Prilosec and Pravastatin sodium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Prilosec

Prilosec has active ingredients of omeprazole. It is often used in gastrooesophageal reflux disease. (latest outcomes from Prilosec 58,542 users)

Pravastatin Sodium

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. (latest outcomes from Pravastatin sodium 8,439 users)

On Jul, 26, 2016

3,630 people who take Prilosec, Pravastatin Sodium are studied.


Number of reports submitted per year:

Prilosec and Pravastatin sodium drug interactions.

Drug effectiveness over time:

Prilosec:
  • < 1 month: 60.0% - (3 of 5 people)
  • 1 - 6 months: 33.0% - (6 of 18 people)
  • 6 - 12 months: 45.0% - (5 of 11 people)
  • 1 - 2 years: 61.0% - (16 of 26 people)
  • 2 - 5 years: 67.0% - (25 of 37 people)
  • 5 - 10 years: 86.0% - (20 of 23 people)
  • 10+ years: 69.0% - (9 of 13 people)
  • not specified: 0.0% - (0 of 0 people)
Pravastatin Sodium:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 42.0% - (8 of 19 people)
  • 6 - 12 months: 18.0% - (2 of 11 people)
  • 1 - 2 years: 21.0% - (6 of 28 people)
  • 2 - 5 years: 42.0% - (12 of 28 people)
  • 5 - 10 years: 42.0% - (8 of 19 people)
  • 10+ years: 88.0% - (15 of 17 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Prilosec:
  • female: 63.0% - (38 of 60 people)
  • male: 63.0% - (46 of 73 people)
Pravastatin Sodium:
  • female: 43.0% - (26 of 60 people)
  • male: 37.0% - (25 of 67 people)

Drug effectiveness by age:

Prilosec:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 55.0% - (5 of 9 people)
  • 40-49: 70.0% - (17 of 24 people)
  • 50-59: 59.0% - (16 of 27 people)
  • 60+: 63.0% - (46 of 73 people)
Pravastatin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (4 of 8 people)
  • 40-49: 25.0% - (5 of 20 people)
  • 50-59: 33.0% - (9 of 27 people)
  • 60+: 45.0% - (33 of 72 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • stevens-johnson syndrome
  • neutropenia
  • cerebral haemorrhage
  • septic shock
  • urinary tract infection
  • asthenia
  • loss of consciousness
  • pleural effusion
  • toxic skin eruption
1 - 6 months:
  • back pain
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • coronary arterial stent insertion
  • heart rate irregular
  • heart valve calcification
  • heart valve incompetence
  • idiopathic thrombocytopenic purpura
  • labile blood pressure
  • loss of consciousness
6 - 12 months:
  • back pain
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • coronary arterial stent insertion
  • heart rate irregular
  • heart valve calcification
  • heart valve incompetence
  • labile blood pressure
  • loss of consciousness
  • syncope
1 - 2 years:
  • renal failure
  • blood creatine increased
  • fatigue
  • sepsis
  • tubulointerstitial nephritis
  • death
  • platelet count decreased
  • weight increased
  • cholelithiasis
  • constipation
2 - 5 years:
  • anxiety
  • renal failure
  • death
  • depression
  • hypomagnesaemia
  • injury
  • pain
  • renal injury
  • anhedonia
  • emotional distress
5 - 10 years:
  • infection
  • arterial disorder
  • blood pressure increased
  • bloody discharge
  • bone disorder
  • open wound
  • pain
  • swelling
  • tooth loss
  • swelling face
10+ years:
  • dizziness
  • itching - vaginal area
  • pain of skin
  • vulvovaginal burning sensation
  • bone pain
  • confusion
  • constipation
  • constipation aggravated
  • dizziness aggravated
  • fatigue - chronic
not specified:
  • pain
  • anxiety
  • nausea
  • dyspnoea
  • fatigue
  • fall
  • back pain
  • pain in extremity
  • diarrhoea
  • anaemia

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • nausea
  • fall
  • back pain
  • dyspnoea
  • pain in extremity
  • fatigue
  • diarrhoea
  • oedema peripheral
male:
  • pain
  • dyspnoea
  • fatigue
  • asthenia
  • anxiety
  • chest pain
  • hypotension
  • nausea
  • injury
  • pyrexia

Most common drug interactions by age *:

0-1:
  • anaemia
  • autoimmune neutropenia
  • blood culture positive
  • cardiomegaly
  • dehydration
  • gastroenteritis viral
  • gastrooesophageal reflux disease
  • gingival hyperplasia
  • hypertension
  • hypophagia
10-19:
  • nephrogenic systemic fibrosis
  • blood phosphorus increased
  • serum ferritin increased
  • blood creatinine increased
  • fluid overload
  • hypotension
  • immune system disorder
  • immunosuppression
  • infection
  • laboratory test abnormal
20-29:
  • anaemia
  • blood creatinine increased
  • upper respiratory tract inflammation
  • anal fissure
  • dehydration
  • dizziness
  • haematochezia
  • hypokalaemia
  • hypotension
  • occult blood positive
30-39:
  • nausea
  • abdominal pain
  • cholecystitis acute
  • cholelithiasis
  • gastritis
  • pancreatitis acute
  • urinary tract infection
  • fatigue
  • liver function test abnormal
  • pain
40-49:
  • chest pain
  • pain
  • myocardial infarction
  • nausea
  • depression
  • dyspnoea
  • headache
  • fatigue
  • insomnia
  • renal failure acute
50-59:
  • pain
  • anxiety
  • oedema peripheral
  • diarrhoea
  • fatigue
  • nausea
  • injury
  • pain in extremity
  • osteoarthritis
  • pyrexia
60+:
  • fall
  • dyspnoea
  • pain
  • fatigue
  • anxiety
  • back pain
  • asthenia
  • nausea
  • anaemia
  • pain in extremity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Prilosec and Pravastatin sodium?

Can you answer these questions?

More questions for: Prilosec, Pravastatin sodium

You may be interested in these reviews

More reviews for: Prilosec, Pravastatin sodium

On eHealthMe, Prilosec (omeprazole) is often used to treat gastrooesophageal reflux disease. Pravastatin sodium (pravastatin sodium) is often used to treat high blood cholesterol. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.